Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1965 1
1967 2
1968 2
1969 2
1970 2
1971 2
1973 1
1974 3
1976 1
1977 1
1978 4
1979 4
1980 5
1981 6
1982 4
1983 6
1984 7
1985 6
1986 15
1987 16
1988 21
1989 20
1990 20
1991 33
1992 28
1993 31
1994 34
1995 23
1996 11
1997 4
1998 4
1999 4
2000 7
2001 5
2002 5
2003 5
2004 2
2005 2
2007 3
2009 4
2010 2
2011 4
2012 2
2013 4
2014 3
2015 5
2016 7
2017 6
2018 3
2019 3
2020 5
2021 8
2022 12
2023 13
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

421 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial.
Mosele F, Deluche E, Lusque A, Le Bescond L, Filleron T, Pradat Y, Ducoulombier A, Pistilli B, Bachelot T, Viret F, Levy C, Signolle N, Alfaro A, Tran DTN, Garberis IJ, Talbot H, Christodoulidis S, Vakalopoulou M, Droin N, Stourm A, Kobayashi M, Kakegawa T, Lacroix L, Saulnier P, Job B, Deloger M, Jimenez M, Mahier C, Baris V, Laplante P, Kannouche P, Marty V, Lacroix-Triki M, Diéras V, André F. Mosele F, et al. Among authors: kakegawa t. Nat Med. 2023 Aug;29(8):2110-2120. doi: 10.1038/s41591-023-02478-2. Epub 2023 Jul 24. Nat Med. 2023. PMID: 37488289 Free PMC article. Clinical Trial.
Boron-assisted abiotic polypeptide synthesis.
Sumie Y, Sato K, Kakegawa T, Furukawa Y. Sumie Y, et al. Among authors: kakegawa t. Commun Chem. 2023 May 11;6(1):89. doi: 10.1038/s42004-023-00885-7. Commun Chem. 2023. PMID: 37169868 Free PMC article.
Tumor steatosis and glutamine synthetase expression in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy.
Kurebayashi Y, Tsujikawa H, Sugimoto K, Yunaiyama D, Araki Y, Saito K, Takahashi H, Kakegawa T, Wada T, Tomita Y, Abe M, Yoshimasu Y, Takeuchi H, Hirata T, Sakamaki K, Kakimi K, Nagao T, Itoi T, Sakamoto M. Kurebayashi Y, et al. Among authors: kakegawa t. Hepatol Res. 2023 Oct;53(10):1008-1020. doi: 10.1111/hepr.13933. Epub 2023 Jun 23. Hepatol Res. 2023. PMID: 37300323
Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy.
Hayakawa Y, Tamaki N, Nakanishi H, Kurosaki M, Tanaka Y, Inada K, Ishido S, Kirino S, Yamashita K, Nobusawa T, Matsumoto H, Kakegawa T, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Kaneko S, Yasui Y, Takahashi Y, Tsuchiya K, Okamoto R, Izumi N. Hayakawa Y, et al. Among authors: kakegawa t. Intern Med. 2023 Apr 1;62(7):973-978. doi: 10.2169/internalmedicine.0212-22. Epub 2022 Sep 6. Intern Med. 2023. PMID: 36070941 Free PMC article.
Racemization of Valine by Impact-Induced Heating.
Furukawa Y, Takase A, Sekine T, Kakegawa T, Kobayashi T. Furukawa Y, et al. Among authors: kakegawa t. Orig Life Evol Biosph. 2018 Mar;48(1):131-139. doi: 10.1007/s11084-017-9539-0. Epub 2017 May 9. Orig Life Evol Biosph. 2018. PMID: 28484901
Conversion surgery for hepatocellular carcinoma after tyrosine kinase inhibitor treatment.
Kaneko S, Tsuchiya K, Yasui Y, Tanaka Y, Inada K, Ishido S, Kirino S, Yamashita K, Hayakawa Y, Nobusawa T, Matsumoto H, Kakegawa T, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Tamaki N, Takahashi Y, Nakanishi H, Irie T, Ariizumi SI, Kurosaki M, Izumi N. Kaneko S, et al. Among authors: kakegawa t. JGH Open. 2022 Apr 21;6(5):301-308. doi: 10.1002/jgh3.12735. eCollection 2022 May. JGH Open. 2022. PMID: 35601130 Free PMC article.
Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma.
Kaneko S, Kurosaki M, Tsuchiya K, Yasui Y, Hayakawa Y, Inada K, Tanaka Y, Ishido S, Kirino S, Yamashita K, Nobusawa T, Matsumoto H, Kakegawa T, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Tamaki N, Takahashi Y, Nakanishi H, Izumi N. Kaneko S, et al. Among authors: kakegawa t. PLoS One. 2022 Mar 10;17(3):e0265235. doi: 10.1371/journal.pone.0265235. eCollection 2022. PLoS One. 2022. PMID: 35271670 Free PMC article.
421 results